Contrast the Antigen Expression Levels Between A1 and A2 Individuals
The primary difference between the A1 and A2 subgroups of blood type A lies in the density and complexity of the antigens expressed on cell surfaces, including the renal endothelium. While A1 is the most common subgroup, A2 individuals are considered “low expressers,” posing a lower immunological barrier in kidney transplantation.
Infographic: A1 vs. A2 Comparison
Feature | A1 Subgroup (High Expresser) | A2 Subgroup (Low Expresser) |
|---|---|---|
Frequency | ~80% of Group A population | ~20% of Group A population |
Antigen Density | High density of A antigens | Sparse (roughly 75% less expression) |
Molecular Structure | Dense, branched carbohydrate chains | Fewer, simpler antigen structures |
Chemical Marker | Contains glycolipid type 4 chain | Lacks glycolipid type 4 chain |
Reactivity | Agglutinates with Dolichos biflorus lectin | No reactivity with Dolichos biflorus |
Transplant Risk | High risk of antibody-mediated injury | “Stealthier”; lower risk of rejection |
Key Distinctions and Clinical Impact
- Weakened Antigenicity:
Because A2 kidneys express markedly fewer A epitopes, the recipient’s anti-A antibodies are often too weak to cause significant graft injury. - A2-to-B Transplant Feasibility:
In A2-to-B living donor transplants, clinicians can often avoid aggressive desensitization (such as antibody removal) if the recipient’s IgG titers are low—typically ≤1:8 to 1:16.
Deceased Donor Allocation:
In the U.S. and UK, deceased-donor A2 kidneys are increasingly allocated to blood group B recipients. This strategy reduces waiting times for Group B candidates and results in outcomes comparable to compatible transplants.
